It was reported that during the clinical trial, the patient had a minor ischemic stroke in the internal carotid aneurysm (ophthalmic tract), one day post procedure with the subject flow diverter.
Imaging documented small hyperintense spots that could represent either micro-emboli or contrast media toxicity.
In the physician's opinion, the event was related to the subject flow diverter.
No medication was administered in response to the event and patient is reported to be asymptomatic.
Event has completely resolved.
No other information is available.
|